Idi na sadržaj

Trauma i hitna medicina

Kontroliranje i optimizacija hemostaze

Antifibrinolitička sredstva

Alternatives to allogeneic platelet transfusion. (otvara se novi prozor)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Izvor‎: Br J Haematol 2016;175(3):381-92.

Indeks‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (otvara se novi prozor)

Antifibrinolytic drugs for acute traumatic injury. (otvara se novi prozor)

Ker K, Roberts I, Shakur H, Coats TJ.

Izvor‎: Cochrane Database Syst Rev 2015;(5):CD004896.

Indeks‎: PubMed 25956410

DOI‎: 10.1002/14651858.CD004896.pub4

https://www.ncbi.nlm.nih.gov/pubmed/25956410 (otvara se novi prozor)

Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. (otvara se novi prozor)

Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE.

Izvor‎: JAMA Surg 2013;148(3):218-25.

Indeks‎: PubMed 23670117

DOI‎: 10.1001/jamasurg.2013.764

https://www.ncbi.nlm.nih.gov/pubmed/23670117 (otvara se novi prozor)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (otvara se novi prozor)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Izvor‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Indeks‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (otvara se novi prozor)

Rekombinirani aktivirani faktor VII (rFVIIa)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (otvara se novi prozor)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Izvor‎: Transfusion 2009;49 Suppl 5:240S-7S.

Indeks‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (otvara se novi prozor)

Koncentrati faktora zgrušavanja

The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. (otvara se novi prozor)

Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M.

Izvor‎: Injury 2013;44(2):209-16.

Indeks‎: PubMed 23000050

DOI‎: 10.1016/j.injury.2012.08.047

https://www.ncbi.nlm.nih.gov/pubmed/23000050 (otvara se novi prozor)

Dezmoprezin

Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury. (otvara se novi prozor)

Furay EJ, Daley MJ, Satarasinghe P, Lara S, Aydelotte JD, Teixeira PG, Coopwood TB, Ali S, Brown CVR

Izvor‎: J Trauma Acute Care Surg 2020;88(1):80-6.

Indeks‎: PubMed 31688782

DOI‎: 10.1097/TA.0000000000002521

https://www.ncbi.nlm.nih.gov/pubmed/31688782 (otvara se novi prozor)

Viskoelastični testovi za otkrivanje kirurškog ili koagulopatijskog krvarenja

Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. (otvara se novi prozor)

Brenni M, Worn M, Brüesch M, Spahn DR, Ganter MT.

Izvor‎: Acta Anaesthesiol Scand 2010;54(1):111-7.

Indeks‎: PubMed 19860752

DOI‎: 10.1111/j.1399-6576.2009.02132.x

https://www.ncbi.nlm.nih.gov/pubmed/19860752 (otvara se novi prozor)